RMD Open


Publication Venue For

  • Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.  8. 2022
  • Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies.  8. 2022
  • Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.  7. 2021
  • Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) common language definition of gout.  7. 2021
  • Comparative effectiveness of biologics and targeted therapies for psoriatic arthritis.  7. 2021
  • Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy.  6. 2020
  • Long-term safety of tofacitinib up to 9.5 years: A comprehensive integrated analysis of the rheumatoid arthritis clinical development programme.  6. 2020
  • Trends of lymphoma incidence in US veterans with rheumatoid arthritis, 2002-2017.  6. 2020
  • Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: A Latin American perspective.  6. 2020
  • Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting.  5. 2019
  • Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: A pooled analysis of 11 317 patients across clinical trials.  5. 2019
  • Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: Results from LUMINA (LXXIX), a multiethnic, multicentre US cohort.  5. 2019
  • Gout and the risk of incident atrial fibrillation in older adults: a study of US Medicare data..  4:e000712. 2018
  • Influence of genetic variants on renal uric acid handling in response to frusemide: An acute intervention study.  3. 2017
  • EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: A methodology report.  3. 2017
  • Multiple common and rare variants of ABCG2 cause gout.  3. 2017
  • Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.  2. 2016
  • PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis.  2. 2016
  • International Standard Serial Number (issn)

  • 2056-5933
  • Electronic International Standard Serial Number (eissn)

  • 2056-5933